Horizon Ventures

Horizon Ventures is a Hong Kong-based venture capital firm established in 2002, specializing in technology-focused investments across various sectors. With a global presence, the firm targets seed, early-stage, and late-stage opportunities, particularly in artificial intelligence, machine learning, fintech, healthcare technology, and software as a service (SaaS). Horizon Ventures is known for its disruptive investment strategy, having achieved notable exits in successful companies such as Skype, Siri, Facebook, Summly, and Waze. Through its strategic investments, the firm aims to support innovative startups that have the potential to reshape their respective industries.

Raymond Ng

Director

Jason Wong

Director

291 past transactions

Normative.io

Series B in 2022
Normative is the only software capable of assessing a company’s social and environmental impact automatically by analysing their purchases,using artificial intelligence combined with the world's largest sustainability research database.Their goal is to make the social and environmental cost of every purchase in their economy transparent.This will enable humanity to move towards achieving the Sustainable Development Goals together.

Spiderwort

Series A in 2022
Spiderwort is a Canadian company based in Ottawa, founded in 2015, that specializes in developing biomaterials for regenerative medicine. The company focuses on creating plant-derived cellulose-based biomaterials, which are engineered to form various scaffold architectures. These innovative biomaterials aim to facilitate the repair and regeneration of tissues within the human body, including applications for spinal cord injury repair and soft tissue regeneration. Currently in the pre-clinical stage, Spiderwort's products show promising results in terms of biocompatibility and the ability to induce angiogenesis, which is the generation of new blood vessels within the scaffolds. By utilizing both biological and synthetic polymers, Spiderwort offers a range of product forms, including powders, gels, membranes, and pastes, contributing to advancements in healthcare and regenerative therapies.

wefox

Series D in 2022
wefox is a digital insurance company based in Berlin, Germany, founded in 2015. It aims to enhance safety and minimize risks by transforming the insurance landscape through technology. The company focuses on selling insurance through intermediaries rather than direct channels, leveraging analytics to achieve better loss ratios than the market average. With over 90% straight-through processing, wefox operates a central product factory that enables rapid and cost-effective deployment of product innovations across international markets. The company has established a network of thousands of digitally enabled advisors throughout Europe, which enhances customer satisfaction, reduces customer acquisition costs, and improves cross-selling opportunities while decreasing churn.

Keel Labs

Series A in 2022
Keel Labs, formerly known as AlgiKnit Inc., is a biomaterials company focused on developing sustainable materials for the textile industry. Founded in 2017 and based in New York, the company specializes in producing yarn spun from kelp and converting seaweed into fiber. By integrating scientific innovation with design, Keel Labs aims to create environmentally friendly alternatives to traditional textile materials, addressing the growing demand for sustainability in fashion and textile production.

Atomo Coffee

Series A in 2022
Atomo Coffee Inc, founded in 2019 and based in Seattle, Washington, specializes in the production of molecular coffee. The company has innovatively reverse-engineered the coffee bean to create a smooth, flavorful cup of coffee using naturally derived ingredients. This approach not only enhances the taste but also promotes sustainability compared to traditional coffee production methods.

Manifold Bio

Series A in 2022
Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is building a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics. It was founded in 2020 and headquartered in Boston, Massachusetts.

getquin

Series A in 2022
Getquin, founded in January 2020 and based in Berlin, Germany, develops an investment software platform that assists users in managing and optimizing their investment portfolios. The application serves as a personalized investment advisor, enabling users to construct tailored ETF portfolios and track their performance across various brokerage accounts. It simplifies the investment process by providing tools for monitoring existing trading accounts and evaluating the performance of selected securities. With a focus on enhancing user experience in navigating the complex financial landscape, Getquin aims to make investing more accessible and efficient for individuals.

Voyage Foods

Series A in 2022
Voyage Foods has made sustainable and scalable alternatives to foods that have current obstacles –environmental, social, and health alike. Our breakthrough technology provides endless opportunities to make delicious, nearly identical, versions of beloved foods, without compromising individual health or our planet. We replicated the world’s favorite foods so that we can all enjoy them, forever.

Kelonia

Series A in 2022
Developer of genetic medicines intended to treat cancer and other immune diseases. The company's medicines provide elegant cutting-edge in vivo gene delivery technology that uses potent lentiviral vector-like particles to precisely deliver in vivo genetic cargo to the desired target tissue, enabling physicians to get a pipeline of drugs for solid tumors and hematologic cancers and other immune diseases.

Ansa Biotechnologies

Series A in 2022
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Established in 2018, the company aims to improve upon traditional chemical methods of DNA synthesis that have remained largely unchanged for decades. Ansa's enzymatic approach offers significant advantages, including increased speed, accuracy, and cleanliness in the production of DNA fragments such as oligonucleotides. This technology enhances the capabilities of biological research, therapeutics, diagnostics, and biomanufacturing by enabling the synthesis of gene-length oligonucleotides. Through its advancements, Ansa Biotechnologies seeks to facilitate innovation in the fields of biological research and engineering, ultimately providing valuable services to medical researchers and contributing to the broader biotechnology landscape.

Micro Connect

Series B in 2022
Micro Connect provides market infrastructure, fintech, and platform development.

Concerto Biosciences

Venture Round in 2022
Concerto Biosciences discovers and develops specific combinations of microbial ensembles. Using kChip, a patented, high-throughput platform that constructs and screens millions of defined microbial communities - Concerto creates massive data sets on how microbes function when growing in complex communities. From these data, Concerto directly discovers microbial ensembles that perform a desired task and learns design rules for ensemble engineering.

Deepcell

Series B in 2022
Deepcell, Inc. is a company based in Mountain View, California, focused on advancing diagnostic technologies through a non-invasive approach. Founded in 2015, it has developed a microfluidic imaging platform that leverages artificial intelligence to classify cells by their visual features. This technology allows for the isolation of viable cells based on their morphological characteristics, facilitating detailed genetic health assessments from standard blood samples. By enabling insights at the single-cell level, Deepcell aims to improve the diagnosis and treatment of various diseases, offering researchers a valuable alternative to invasive diagnostic methods.

Soul Machines

Series B in 2022
Soul Machines Limited develops emotionally responsive avatars that augment and enrich the user experience for artificial intelligence (AI) platforms. The company’s products include Digital DNA Studio, which allows user to build custom digital people for customer care, sales and marketing, brand and influencer, product, wellbeing, people and performance, training and education, and digital innovation purposes. The company was incorporated in 2016 and is headquartered in Auckland, New Zealand with additional offices in San Francisco and Los Angeles, California; New York, New York; London, United Kingdom; Tokyo, Japan; and Melbourne, Australia.

H2Pro

Series B in 2022
H2Pro, Ltd. is a company that specializes in innovative water-splitting technology aimed at producing hydrogen fuel. Founded in 2019 and based in Caesarea, Israel, H2Pro has developed a proprietary electrolysis method known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting). This technology effectively separates the hydrogen and oxygen evolution reactions, offering a super-efficient approach to green hydrogen production.

Fertilis

Seed Round in 2022
Fertilis is a company focused on enhancing the in vitro fertilization (IVF) experience for both patients and clinicians. It specializes in developing innovative IVF technology that automates cell culture using micromedical devices. This technology standardizes and automates the IVF process, ensuring better protection for embryos. By utilizing patented micro-3D printed pods, Fertilis creates an optimized growth environment that improves the nutritive composition of solutions used during embryo cultivation. This approach aims to make the IVF process less stressful and more successful, benefiting medical professionals and their patients alike.

MeMed

Venture Round in 2022
MeMed Diagnostics Ltd. is a personalized diagnostics company established in 2009 and headquartered in Tirat Carmel, Israel. The company specializes in developing innovative diagnostic solutions aimed at improving patient care and reducing healthcare costs associated with infectious diseases. Its flagship products include MeMed BV, a test that differentiates between bacterial and viral infections, and the ImmunoDx platform, which accurately identifies the source of infection by analyzing the immune system's response to various pathogens. This technology helps prevent the misuse of antibiotics, a significant issue as up to 70% of antibiotic prescriptions are estimated to be inappropriate, leading to ineffective treatments and the rise of antibiotic-resistant strains. MeMed's approach combines proprietary biomarkers, algorithms, and clinical expertise to address the critical diagnostic gaps in managing infectious diseases, thereby enhancing the effectiveness of treatment and minimizing unnecessary healthcare expenditures.

Eikon Therapeutics

Series B in 2022
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Established in 2019, Eikon utilizes advanced super-resolution microscopy techniques, enabling real-time, molecular-resolution measurements of protein movement in living cells. This unique discovery platform allows the company to target previously difficult-to-address biological targets, leveraging groundbreaking innovations from its founders, including a Nobel Prize recipient. Through these efforts, Eikon aims to create novel therapeutics that address unmet medical needs.

Kopi Kenangan

Series C in 2021
Kopi Kenangan is one of several grab-and-go coffee chains trying to capitalize on the rising trend and demand for grounded coffee beverages in a country which has the lowest coffee consumption per capita in the region, despite being the world’s fourth-largest coffee exporter.

ZeroAvia

Series B in 2021
ZeroAvia, Inc. designs zero-emission aircraft specifically for commercial short-haul trips. Founded in 2017 by Val Miftakhov, the company is headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom. ZeroAvia develops a hydrogen fuel cell system that powers electric propulsion, enabling practical zero-emission aviation. The company initially targets a travel range of 500 miles for regional aircraft accommodating 10 to 20 passengers. This innovative approach significantly reduces operational costs, offering four times lower fuel and engine maintenance expenses compared to traditional aviation solutions.

Wonder Dynamics

Series A in 2021
Wonder Dynamics develops and combines AI technology with storytelling. The media-tech startup developing an AI production tool that would allow indie filmmakers to deliver blockbuster-level VFX on a fraction of the budget. Tye Sheridan and Nikola Todorovic co-founded the company in Los Angeles, California.

Notpla

Series A in 2021
Notpla Limited, based in London, manufactures innovative packaging products primarily for beverages and sauces. The company specializes in creating advanced packaging solutions, including sachets and waterproof, grease-proof cardboard takeaway boxes. Founded in 2014 and previously known as Skipping Rocks Lab Limited, Notpla aims to develop packaging that is environmentally friendly and degrades naturally. By combining design, chemistry, and engineering expertise, Notpla is at the forefront of sustainable packaging solutions, addressing the growing demand for alternatives to traditional plastic packaging.

Harrison.ai

Series B in 2021
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools that integrate into existing clinical workflows which ultimately lead to improved patient outcomes. Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images. Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients. Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.

Q-CTRL

Series B in 2021
Q-CTRL Pty Ltd, established in 2017 and located in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. The company focuses on addressing critical challenges in quantum technology, such as noise and decoherence, which affect the performance of quantum devices. By leveraging its expertise in quantum control engineering, Q-CTRL provides intuitive software solutions designed to reduce errors in quantum bits, thereby stabilizing quantum hardware. Its offerings are particularly relevant in the NISQ (Noisy Intermediate-Scale Quantum) era, allowing users to better understand and manage the impacts of noise and errors in quantum systems. Through its innovative approach, Q-CTRL aims to make quantum technology more practical and accessible for various applications, including quantum sensing in defense.

Fleet Space Technologies

Series B in 2021
Fleet Space Technologies Pty Ltd designs, builds, and launches satellites for global satellite connectivity to the Internet of things (IoT). It builds a network of tiny satellites to deliver backhaul service for the Internet of Things that gives coverage to devices worldwide. The company serves mining, oil and gas resources, precision agriculture, and transport and logistics sectors. Fleet Space Technologies Pty Ltd was founded in 2015 and is based in Beverley, Australia.

Synthace

Series C in 2021
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Seasoned

Series A in 2021
Seasoned, LLC operates a professional networking platform specifically designed for foodservice industry professionals, including cooks, dishwashers, servers, and gig workers. Based in San Francisco with an additional office in Austin, the company connects workers with job opportunities and fosters career development. Seasoned offers resources such as video courses and articles to help individuals enhance their skills and succeed in their careers. The platform also facilitates networking among foodservice workers, allowing them to share tools, build teams, and improve retention and customer experiences. Founded by a team with extensive experience in the restaurant sector, Seasoned addresses the unique challenges faced by foodservice professionals while promoting growth and collaboration within the industry.

Loam Bio

Series A in 2021
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.

Ansa Biotechnologies

Funding Round in 2021
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Established in 2018, the company aims to improve upon traditional chemical methods of DNA synthesis that have remained largely unchanged for decades. Ansa's enzymatic approach offers significant advantages, including increased speed, accuracy, and cleanliness in the production of DNA fragments such as oligonucleotides. This technology enhances the capabilities of biological research, therapeutics, diagnostics, and biomanufacturing by enabling the synthesis of gene-length oligonucleotides. Through its advancements, Ansa Biotechnologies seeks to facilitate innovation in the fields of biological research and engineering, ultimately providing valuable services to medical researchers and contributing to the broader biotechnology landscape.

Ajaib

Series B in 2021
Ajaib is an online wealth management platform based in Jakarta, Indonesia, that facilitates automatic saving and investing for its users. Founded in 1990, the platform enables Indonesians to buy and sell a variety of financial products, including stocks, exchange-traded funds (ETFs), and mutual funds. Ajaib aims to simplify the investment process, making it accessible for a broader audience in Indonesia.

Perfect Day

Series D in 2021
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Catalog

Series B in 2021
CATALOG is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Prospection

Series B in 2021
Prospection Pty Ltd is a Sydney-based company specializing in healthcare data analytics through its software as a service (SaaS) platforms. Founded in 2012, it leverages predictive analytics and machine learning to analyze real-world healthcare data, providing insights that enhance research and improve patient outcomes. The company's key offerings include PharmDash, which tracks patient medication usage and treatment progression, and PharmMap, a platform that integrates commercial and operational data using geospatial mapping. Prospection collaborates with government entities, pharmaceutical companies, and the medical community on over 70 therapy programs, with a focus on areas such as immuno-oncology, HIV, and hepatitis across Australia and the Asia Pacific region.

Owlstone Medical

Series D in 2021
Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, that specializes in developing non-invasive breath analyzers for clinical diagnostics and precision medicine. The company’s Breath Biopsy platform utilizes advanced technologies such as FAIMS to detect volatile organic compounds (VOCs) in breath, enabling the identification of biomarkers for various diseases, including lung cancer, colorectal cancer, asthma, and inflammatory bowel diseases. Owlstone Medical aims to improve early diagnosis and treatment outcomes, potentially saving 100,000 lives and reducing healthcare costs significantly. The company offers several products, including the award-winning ReCIVA Breath Sampler and other tools designed for disease biomarker detection. With ongoing collaborations and contracts, including a partnership with the UK National Health Service for lung cancer trials, Owlstone Medical is focused on transforming non-invasive diagnostics and is actively pursuing developments that could lead to portable, hand-held diagnostic devices.

Alpaca

Series B in 2021
Alpaca is a technology company based in San Mateo, California, that operates as a securities broker. It specializes in providing an algorithmic trading platform designed for developers to create, manage, and execute trading and investing algorithms. The Alpaca API enables the development of investing applications and brokerage services that facilitate commission-free trading. The company boasts a team with diverse backgrounds in finance and technology and has garnered support from prominent investors in the industry. By focusing on empowering developers, Alpaca aims to enhance access to financial markets through innovative technology solutions.

v2food

Series B in 2021
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

ZeroAvia

Venture Round in 2021
ZeroAvia, Inc. designs zero-emission aircraft specifically for commercial short-haul trips. Founded in 2017 by Val Miftakhov, the company is headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom. ZeroAvia develops a hydrogen fuel cell system that powers electric propulsion, enabling practical zero-emission aviation. The company initially targets a travel range of 500 miles for regional aircraft accommodating 10 to 20 passengers. This innovative approach significantly reduces operational costs, offering four times lower fuel and engine maintenance expenses compared to traditional aviation solutions.

Modern Meadow

Series C in 2021
Modern Meadow, LLC is a biofabrication company established in 2011 and headquartered in Brooklyn, New York. The company specializes in producing animal-free leather and other cultured products, such as meat alternatives, through innovative methods that eliminate the need for animal slaughter. By utilizing living cells and fermentation-based processes, Modern Meadow develops lightweight materials that provide superior color, performance, and durability, while also promoting lab-to-brand traceability. Their approach significantly reduces the inputs of land, water, energy, and chemicals, contributing to lower greenhouse gas emissions. This focus on sustainability enables customers to maintain the quality and appearance of materials without relying on petrochemical inputs or animal-derived substances.

Syzygy Plasmonics

Series B in 2021
Syzygy Plasmonics is a developer of a photocatalytic reactor designed for fuel cell vehicles and small-scale industrial applications.The company's reactor is powered by light and operates at over 1,000°F lower temperature than conventional chemical reactor technology that helps in reducing maintenance costs and is able to start or stop production near instantaneously, enabling fuel cell vehicle companies to produce ultra-low-cost hydrogen gas on-site at customer locations.

Endless West

Series B in 2021
Endless West is a beverage startup using scientific production methods to create its own original blend of wines and spirits. Its winery uses molecules from plants, animals, and substances for taste, smell, and color and combines them to create sustainable wine without any grapes, yeast, or any kind of fermentation. The company's first product, Glyph, is the first aged-style spirit made using flavor and aroma molecules extracted from more efficient sources in nature. Glyph is made without aging or barreling which means significantly less wood, water, and land is used in its production process. Endless West was founded in 2015 and is headquartered in San Francisco, California.

ZeroAvia

Series A in 2021
ZeroAvia, Inc. designs zero-emission aircraft specifically for commercial short-haul trips. Founded in 2017 by Val Miftakhov, the company is headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom. ZeroAvia develops a hydrogen fuel cell system that powers electric propulsion, enabling practical zero-emission aviation. The company initially targets a travel range of 500 miles for regional aircraft accommodating 10 to 20 passengers. This innovative approach significantly reduces operational costs, offering four times lower fuel and engine maintenance expenses compared to traditional aviation solutions.

Ajaib

Series A in 2021
Ajaib is an online wealth management platform based in Jakarta, Indonesia, that facilitates automatic saving and investing for its users. Founded in 1990, the platform enables Indonesians to buy and sell a variety of financial products, including stocks, exchange-traded funds (ETFs), and mutual funds. Ajaib aims to simplify the investment process, making it accessible for a broader audience in Indonesia.

Keel Labs

Venture Round in 2021
Keel Labs, formerly known as AlgiKnit Inc., is a biomaterials company focused on developing sustainable materials for the textile industry. Founded in 2017 and based in New York, the company specializes in producing yarn spun from kelp and converting seaweed into fiber. By integrating scientific innovation with design, Keel Labs aims to create environmentally friendly alternatives to traditional textile materials, addressing the growing demand for sustainability in fashion and textile production.

Voyage Foods

Seed Round in 2021
Voyage Foods has made sustainable and scalable alternatives to foods that have current obstacles –environmental, social, and health alike. Our breakthrough technology provides endless opportunities to make delicious, nearly identical, versions of beloved foods, without compromising individual health or our planet. We replicated the world’s favorite foods so that we can all enjoy them, forever.

ALE

Series A in 2021
To Create world-first man-made meteor shower with releasing particles from micro-satellite, ALE has been founded in 2011. We have unique marketers, engineers, and scientists driven by curiosity, bold enough to create cutting-edge technologies to sublimate space and entertainment concepts. We basically fuse meteor sciences and space technologies to entertain people on ground and predict climate change. We pioneer space entertainment. We have 2 goals. 1. Entertain people to stimulate people's curiosity and empower them to explore their infinite possibilities. 2. Collect mesosphere data. We will federate a wide community from scientists to decision makers and motivate people to elucidate atmosphere phenomena and play a pivotal role in making Earth more sustainable. We are a curiosity-driven company, so we would like to satisfy our curiosity, grow the people's curiosity towards space and science at the same time.

Otter.ai

Series B in 2021
Otter.ai creates technologies and products that make important information from voice conversations including meetings, interviews, and lectures instantly accessible and actionable. The company's award winning product, Otter Voice Notes, is used by business professionals, journalists and students to generate rich notes that can be easily searched and shared. Otter is based on proprietary technologies for speech recognition, speaker separation, speaker ID, and keyword / topic extraction. The company was founded by successful repeat entrepreneur Sam Liang and fellow engineering PhD Yun Fu. Investors We are proud to be supported by some of Silicon Valley’s top venture capitalists who were early investors in Tesla, SpaceX, Slack, and Twitter. Additionally, we are backed by legendary angel investor David Cheriton, who provided the initial capital to Larry Page and Sergey Brin to start Google.

Kuato

Venture Round in 2021
Kuato Games UK Ltd, based in London, is an educational games studio dedicated to enhancing children's learning experiences through video games. Established in 2011, the company develops KUDDLE, an adaptive game engine that fosters engaging and personalized learning environments. Kuato's innovative approach combines high production values with pioneering educational methods, creating games that captivate young learners while ensuring educational effectiveness. The studio is staffed by a diverse team of experts from acclaimed game studios, artificial intelligence, and education sectors, which promotes a culture of creativity and innovation. Additionally, Kuato provides supplementary teaching resources and actively supports teachers interested in incorporating game-based learning into their classrooms. Through these efforts, the company aims to set a new standard in educational gaming, making learning both enjoyable and impactful.

Ajaib

Series A in 2021
Ajaib is an online wealth management platform based in Jakarta, Indonesia, that facilitates automatic saving and investing for its users. Founded in 1990, the platform enables Indonesians to buy and sell a variety of financial products, including stocks, exchange-traded funds (ETFs), and mutual funds. Ajaib aims to simplify the investment process, making it accessible for a broader audience in Indonesia.

Xampla

Seed Round in 2021
Xampla Ltd develops and produces a pea plant protein-based plastic material to replace microplastics for commercial use. The company’s products include microcapsules for application in homecare and personal care products; and films, coatings, and single use plastics for application in single and multi-layer films, coatings, and packaging products. Xampla Ltd was incorporated in 2018 and is based in Cambridge, United Kingdom.

ZeroAvia

Series A in 2020
ZeroAvia, Inc. designs zero-emission aircraft specifically for commercial short-haul trips. Founded in 2017 by Val Miftakhov, the company is headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom. ZeroAvia develops a hydrogen fuel cell system that powers electric propulsion, enabling practical zero-emission aviation. The company initially targets a travel range of 500 miles for regional aircraft accommodating 10 to 20 passengers. This innovative approach significantly reduces operational costs, offering four times lower fuel and engine maintenance expenses compared to traditional aviation solutions.

Refeyn

Series A in 2020
Refeyn specializes in label-free single molecule imaging and mass measurement, offering advanced microscopy solutions for detecting and quantifying molecules. Their technology enables users to perform precise imaging, localization, and accurate mass determination of individual biomolecules in solution. This innovative approach serves various sectors, particularly pharmaceutical, biomedical, and research industries. Founded in 2018 and headquartered in Oxford, United Kingdom, Refeyn aims to enhance research capabilities by providing tools that facilitate a deeper understanding of molecular interactions and properties.

v2food

Series B in 2020
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

Federation Bio

Series A in 2020
Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company's microbial therapy leverages naturally occurring or engineered bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses. This approach has potential in a wide range of human conditions, from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions.

Carmot Therapeutics

Series C in 2020
Carmot Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapies for metabolic diseases, including obesity and diabetes. Founded in 2008 and based in Berkeley, California, with an additional office in San Francisco, the company employs a unique drug discovery approach known as Chemotype Evolution to explore innovative chemistry and biology. Carmot's portfolio includes several drug candidates aimed at treating metabolic disorders and oncology, such as CT-388, a dual GLP-1/GIP receptor agonist designed for obesity and type 2 diabetes, CT-996, an oral small molecule GLP-1 receptor agonist for the same conditions, and CT-868, another dual GLP-1/GIP receptor agonist specifically for type 1 diabetes patients who are overweight or obese. Through these efforts, Carmot Therapeutics seeks to provide effective treatments that improve the quality of life for individuals affected by these diseases.

Brightseed

Venture Round in 2020
Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

Curio

Series A in 2020
Curio Labs Limited is a London-based online media company founded in 2016 that specializes in developing a software application allowing users to listen to curated news articles from various reputable publications, including The Guardian, The Financial Times, and Salon. This innovative platform transforms written content into audio format, providing users with an accessible way to consume news and information. By focusing on high-quality journalism, Curio aims to enhance the reading experience for those who prefer auditory learning or multitasking while staying informed.

Catalog

Series A in 2020
CATALOG is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Atomo Coffee

Seed Round in 2020
Atomo Coffee Inc, founded in 2019 and based in Seattle, Washington, specializes in the production of molecular coffee. The company has innovatively reverse-engineered the coffee bean to create a smooth, flavorful cup of coffee using naturally derived ingredients. This approach not only enhances the taste but also promotes sustainability compared to traditional coffee production methods.

Docket

Seed Round in 2020
Docket, Inc. is an Indianapolis-based company that offers an online platform focused on enhancing meeting productivity. Founded in 2018, Docket's platform facilitates collaborative agenda creation, decision documentation, and action item tracking, allowing teams to lead effective meetings and maintain alignment on goals. The platform is designed to support users in planning their daily and weekly activities, ensuring that meetings are both productive and purposeful. Through its meeting intelligence capabilities, Docket aims to improve leadership and participation in essential business processes.

Perfect Day

Series C in 2020
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Loam Bio

Seed Round in 2020
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.

Ansa Biotechnologies

Seed Round in 2020
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Established in 2018, the company aims to improve upon traditional chemical methods of DNA synthesis that have remained largely unchanged for decades. Ansa's enzymatic approach offers significant advantages, including increased speed, accuracy, and cleanliness in the production of DNA fragments such as oligonucleotides. This technology enhances the capabilities of biological research, therapeutics, diagnostics, and biomanufacturing by enabling the synthesis of gene-length oligonucleotides. Through its advancements, Ansa Biotechnologies seeks to facilitate innovation in the fields of biological research and engineering, ultimately providing valuable services to medical researchers and contributing to the broader biotechnology landscape.

Sentropy Technologies

Venture Round in 2020
Sentropy Technologies, Inc., founded in 2018 and headquartered in Palo Alto, California, specializes in developing advanced technologies designed to safeguard digital communities and brands from abuse and harmful content. The company employs machine learning to create tools that effectively combat hate and harassment online. By focusing on enhancing the safety and integrity of digital environments, Sentropy aims to provide solutions that help organizations protect their users and maintain a positive online presence.

Spiderwort

Seed Round in 2020
Spiderwort is a Canadian company based in Ottawa, founded in 2015, that specializes in developing biomaterials for regenerative medicine. The company focuses on creating plant-derived cellulose-based biomaterials, which are engineered to form various scaffold architectures. These innovative biomaterials aim to facilitate the repair and regeneration of tissues within the human body, including applications for spinal cord injury repair and soft tissue regeneration. Currently in the pre-clinical stage, Spiderwort's products show promising results in terms of biocompatibility and the ability to induce angiogenesis, which is the generation of new blood vessels within the scaffolds. By utilizing both biological and synthetic polymers, Spiderwort offers a range of product forms, including powders, gels, membranes, and pastes, contributing to advancements in healthcare and regenerative therapies.

Bobobox Indonesia

Series A in 2020
PT Bobobox Mitra Indonesia is a hospitality company founded in 2017 and headquartered in Bandung, Indonesia. It offers innovative accommodation services designed for travelers and millennial adventurers, allowing them to stay in a more efficient and comfortable manner. In addition to its core services, Bobobox also provides franchise opportunities, enabling others to join its expanding network. The company aims to create spaces where travelers can rest and recharge, catering to the needs of modern commuters and explorers.

Doma

Series C in 2020
Doma, formerly known as States Title Holding, Inc., provides real estate settlement and closing services for residential and commercial transactions across the United States. Founded in 2018 and headquartered in San Francisco, the company specializes in instant underwriting and digital closings, including hybrid options. Utilizing machine intelligence and patented technology, Doma enhances the real estate closing process, making it faster and more cost-effective. Its offerings cater to a diverse clientele, including major bank and non-bank lenders, real estate agents, title agents, and homeowners, aiming to simplify and improve the efficiency of the closing experience while boosting customer satisfaction.

Kopi Kenangan

Series B in 2020
Kopi Kenangan is one of several grab-and-go coffee chains trying to capitalize on the rising trend and demand for grounded coffee beverages in a country which has the lowest coffee consumption per capita in the region, despite being the world’s fourth-largest coffee exporter.

N26

Series D in 2020
N26 offers mobile banking solutions to customers in the European Union through its subsidiary. It provides international money transfer, investment, overdraft, and cash withdrawal and deposit at stores. N26 provides mobile banking services for customers. Its mobile banking services offer online banking that include making and handling of current accounts, fixed accounts, and other banking services, letting customers manage and control their banking details via a smartphone application easily. Maximilian Tayenthal and Valentin Stalf founded Papayer in February 2013, which later became N26, with its headquarters in Berlin in Germany.

Airwallex

Series D in 2020
Airwallex (Hong Kong) Limited offers money changing and remittance service for customs and excise duty department. The company is based in Quarry Bay, Hong Kong.

Prospection

Series A in 2020
Prospection Pty Ltd is a Sydney-based company specializing in healthcare data analytics through its software as a service (SaaS) platforms. Founded in 2012, it leverages predictive analytics and machine learning to analyze real-world healthcare data, providing insights that enhance research and improve patient outcomes. The company's key offerings include PharmDash, which tracks patient medication usage and treatment progression, and PharmMap, a platform that integrates commercial and operational data using geospatial mapping. Prospection collaborates with government entities, pharmaceutical companies, and the medical community on over 70 therapy programs, with a focus on areas such as immuno-oncology, HIV, and hepatitis across Australia and the Asia Pacific region.

Kneron

Series A in 2020
Kneron focuses on the design and development of integrated software and hardware on-device Edge artificial intelligence (AI) solutions for smart home, smart surveillance, smartphones, robots, drones, and IoT devices. Its solutions include AI System-on-Chips (SoCs), visual recognition SDKs, and neural processing unit (NPU) IP. Kneron's vision is to empower AI on everyday devices and build the Edge AI Net.

Soul Machines

Series B in 2020
Soul Machines Limited develops emotionally responsive avatars that augment and enrich the user experience for artificial intelligence (AI) platforms. The company’s products include Digital DNA Studio, which allows user to build custom digital people for customer care, sales and marketing, brand and influencer, product, wellbeing, people and performance, training and education, and digital innovation purposes. The company was incorporated in 2016 and is headquartered in Auckland, New Zealand with additional offices in San Francisco and Los Angeles, California; New York, New York; London, United Kingdom; Tokyo, Japan; and Melbourne, Australia.

MioTech

Series A in 2020
MioTech Information Technology (Shanghai) Co., Limited is an artificial intelligence platform based in Shanghai, China, with additional offices in Hong Kong. Founded in 2016, the company specializes in developing software solutions for investment managers, enabling them to navigate complex data and enhance client service. MioTech's platform integrates and analyzes diverse data sources to streamline the investment process, offering a data-driven experience. Additionally, the company focuses on sustainability and environmental, social, and corporate governance (ESG) data, providing financial institutions, enterprises, and governments with tools to monitor and manage sustainability metrics in real time. MioTech's innovative approach is supported by notable investors, including Horizons Ventures and ZhenFund.

Medal

Series B in 2020
Medal is the easiest way to Create, Watch, Share, and Analyze gaming highlights.

Levelset

Series C in 2019
Levelset helps contractors and suppliers get payment under control, promoting smooth payments and successful projects. By connecting to Levelset’s cloud-based platform, contractors and suppliers can make payment processes easy and simple. Users can easily exchange payment documents like lien waivers, pay applications, and preliminary notices, they see a complete picture of who is on their job, and are encouraged with the resources and knowledge they need to be confident in payment. The results are faster payments and fewer surprises. Levelset was founded in 2007 and is headquartered in New Orleans, Louisiana.

Teraki

Series A in 2019
Teraki GmbH develops software solutions for scaling of Insurance, predictive maintenance, and autonomous driving applications by enabling access to more qualitative data. Its software enables to fulfil low-latency SLAs required by the end-user and ultimately to adapt key KPIs such as cost-per-mile at the highest precision and lowest latency. The software also enables automotive insurance (UBI), predictive maintenance, fleet management and AD applications to perform in high volume, production series. It also offers crash detection, and autonomous driving services. The company was founded in 2014 and is based in Berlin, Germany.

Perfect Day

Series C in 2019
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Harrison.ai

Series A in 2019
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools that integrate into existing clinical workflows which ultimately lead to improved patient outcomes. Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images. Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients. Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.

EcoPackers

Seed Round in 2019
EcoPackers Inc. is a Toronto-based company established in 2018 that specializes in the production and sale of biodegradable packaging materials. The company focuses on creating eco-resins derived from plants, offering a 100% biodegradable alternative to traditional plastic inputs. These eco-resins enable plastic manufacturers globally to develop innovative, non-toxic, and compostable single-use packaging solutions. Through its commitment to sustainability, EcoPackers aims to reduce the environmental impact of plastic packaging.

Genvid Technologies

Series B in 2019
Genvid Technologies develops innovative software tools aimed at enhancing interactive streaming for eSports. Founded in 2016 and based in New York City, the company provides a unique streaming engine that integrates directly with game engines, allowing game developers and broadcasting companies to create tailored broadcasting experiences. Genvid's software includes a software development kit (SDK) that enables developers to incorporate interactive features into their games, facilitating premium broadcasts across various streaming platforms. Their technology allows for real-time adjustments of camera angles, viewer interfaces, and interactive match features, while also providing tools for analyzing player statistics. This approach aims to elevate the experience of live streaming for both audiences and tournament organizers.

v2food

Series A in 2019
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

NANOEGG

Venture Round in 2019
Nanoegg is aiming to create a medical breakthrough from skin research and to realize medical care without the use of needles.

FIDEL API

Series A in 2019
Fidel Limited engages in developing application program interface (API) platform that connects developers to marketing services. The company develops card-linked API, which allows developers and retailers to create apps and connect banking cards with reward services. It manages all heavy lifting in the background and transactional data securely accessible through a single access point so that developer can create web and mobile applications using real-time payment data. The company was founded in 2012 and is based in London, United Kingdom.

Medal

Series A in 2019
Medal is the easiest way to Create, Watch, Share, and Analyze gaming highlights.

Algama

Series A in 2019
Algama SAS produces and distributes microalgae-based food products. Additionally, the company provides Springwave, an antioxidant drink. Algama SAS was founded in 2013 and is headquartered in Evry, France.

Q-CTRL

Series A in 2019
Q-CTRL Pty Ltd, established in 2017 and located in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. The company focuses on addressing critical challenges in quantum technology, such as noise and decoherence, which affect the performance of quantum devices. By leveraging its expertise in quantum control engineering, Q-CTRL provides intuitive software solutions designed to reduce errors in quantum bits, thereby stabilizing quantum hardware. Its offerings are particularly relevant in the NISQ (Noisy Intermediate-Scale Quantum) era, allowing users to better understand and manage the impacts of noise and errors in quantum systems. Through its innovative approach, Q-CTRL aims to make quantum technology more practical and accessible for various applications, including quantum sensing in defense.

ALE

Series A in 2019
To Create world-first man-made meteor shower with releasing particles from micro-satellite, ALE has been founded in 2011. We have unique marketers, engineers, and scientists driven by curiosity, bold enough to create cutting-edge technologies to sublimate space and entertainment concepts. We basically fuse meteor sciences and space technologies to entertain people on ground and predict climate change. We pioneer space entertainment. We have 2 goals. 1. Entertain people to stimulate people's curiosity and empower them to explore their infinite possibilities. 2. Collect mesosphere data. We will federate a wide community from scientists to decision makers and motivate people to elucidate atmosphere phenomena and play a pivotal role in making Earth more sustainable. We are a curiosity-driven company, so we would like to satisfy our curiosity, grow the people's curiosity towards space and science at the same time.

Fleet Space Technologies

Series A in 2019
Fleet Space Technologies Pty Ltd designs, builds, and launches satellites for global satellite connectivity to the Internet of things (IoT). It builds a network of tiny satellites to deliver backhaul service for the Internet of Things that gives coverage to devices worldwide. The company serves mining, oil and gas resources, precision agriculture, and transport and logistics sectors. Fleet Space Technologies Pty Ltd was founded in 2015 and is based in Beverley, Australia.

Atomo Coffee

Seed Round in 2019
Atomo Coffee Inc, founded in 2019 and based in Seattle, Washington, specializes in the production of molecular coffee. The company has innovatively reverse-engineered the coffee bean to create a smooth, flavorful cup of coffee using naturally derived ingredients. This approach not only enhances the taste but also promotes sustainability compared to traditional coffee production methods.

BlueDot

Series A in 2019
BlueDot Inc. specializes in data analytics solutions aimed at tracking and managing infectious diseases. Founded in 2008 and based in Toronto, Canada, the company utilizes a combination of human expertise and artificial intelligence to analyze a wide range of data, including disease outbreaks, healthcare facilities, population demographics, and environmental factors. By integrating these datasets with proprietary algorithms, BlueDot provides critical insights that help governments, healthcare organizations, and businesses protect their populations and mitigate the risks associated with infectious diseases. The company's early warning system is designed to anticipate disease threats and support effective responses, addressing an increasingly urgent public health challenge.

Demetrix

Series A in 2019
Demetrix, Inc. is a biotechnology company that specializes in manufacturing natural medicines through synthetic biology. Established in 2015 and headquartered in Emeryville, California, the company employs advanced genetics and computational technologies to develop innovative drugs. Demetrix focuses on refactoring microbial hosts for gene synthesis, allowing for the engineering of strains that produce co-evolved and bio-inspired medicines as well as nutraceuticals. Additionally, the company is involved in providing medicinal cannabinoid products tailored for the pharmaceutical, supplement, and consumer product sectors.

Niyo Global

Series B in 2019
Niyo Global is a financial technology company founded in 2015 and based in Palo Alto, California. The company specializes in digital banking solutions, focusing on helping salaried employees access various company benefits and financial services. Niyo partners with employers and banks to provide a digital platform that allows employees to utilize their benefits, such as healthcare and food allowances, through a mobile app designed for submitting claims. Additionally, Niyo offers a comprehensive payroll management platform that includes features for managing taxes and expenses, along with expense management cards and digital accounts that support multiple wallets. This enables users to effectively manage their personal finances and investment options.

Kytopen

Seed Round in 2019
Kytopen Corp. is a biotechnology company based in Cambridge, Massachusetts, focused on advancing cell therapy through its innovative Flowfect technology. Established in 2017, Kytopen specializes in non-viral delivery systems for molecules into challenging immune cells that are typically hard to transfect. The company utilizes a combination of microfluidics and automation to streamline the delivery process, making it faster, more efficient, and cost-effective. By employing a unique platform that integrates continuous fluid flow with electric fields, Kytopen enables researchers to produce high-quality engineered cells in a matter of minutes while preserving their health and functionality. This approach supports the discovery of novel biological insights and the development of affordable cell and gene therapies.

Trint

Series A in 2019
Trint Limited operates an online platform for searching, editing, and getting audio and video content. The company’s platform enables customers to convert their audio and video files into text, polish transcripts to perfect in minutes, make their audio and video files searchable, put captions on their videos, and share bite-sized chunks of audio and video content online. It serves customers in various industries, including journalism and media, video editing, academic research, and market research and user experience. The company was founded in 2014 and is based in London, United Kingdom.

Teraki

Venture Round in 2019
Teraki GmbH develops software solutions for scaling of Insurance, predictive maintenance, and autonomous driving applications by enabling access to more qualitative data. Its software enables to fulfil low-latency SLAs required by the end-user and ultimately to adapt key KPIs such as cost-per-mile at the highest precision and lowest latency. The software also enables automotive insurance (UBI), predictive maintenance, fleet management and AD applications to perform in high volume, production series. It also offers crash detection, and autonomous driving services. The company was founded in 2014 and is based in Berlin, Germany.

Airwallex

Series C in 2019
Airwallex (Hong Kong) Limited offers money changing and remittance service for customs and excise duty department. The company is based in Quarry Bay, Hong Kong.

Evolv AI

Series A in 2019
Evolv Technology Solutions Inc. specializes in developing software solutions aimed at enhancing customer engagement for enterprises. The company offers an AI-driven platform called Ascend, which helps businesses convert visitors into customers by facilitating simultaneous testing of various website and mobile app improvements. Ascend incorporates advanced features such as multivariate testing, funnel optimization, real-time insights, and autonomous optimization, all designed for seamless integration and user-friendly experience. Evolv serves a diverse range of sectors, including e-commerce, travel, financial services, telecommunications, and automotive industries, providing tools that continuously enhance digital optimization and improve customer journeys. Established in 2019 and headquartered in San Francisco, California, with an additional office in Amsterdam, Evolv emerged from Sentient Technologies, drawing on a decade of expertise in evolutionary algorithms to deliver high-value solutions for enterprise clients.

Surrozen

Series B in 2019
Surrozen, Inc. is a biopharmaceutical company based in South San Francisco, California, that specializes in developing targeted regenerative antibodies aimed at repairing tissues and organs affected by serious diseases. The company utilizes antibody platforms that act as Wnt and R-spondin mimetics to stimulate cell and organ-specific tissue regeneration. Its key programs include SZN-043, which is designed to promote hepatocyte regeneration in both acute and chronic liver diseases, and SZN-1326, an intestine-specific Wnt-mimetic intended to repair diseased epithelial tissue for patients suffering from inflammatory bowel disease. Surrozen was incorporated in 2015 and is focused on harnessing the body's self-renewal capabilities through precise control of the Wnt signaling pathway.